About
Jeffrey R. Stewart is AbbVie's Executive Vice President, Chief Commercial Officer. He previously served as Senior Vice President, U.S. Commercial Operations and as President, U.S. Commercial Operations, and before AbbVie's separation from Abbott was Vice President of Abbott's Proprietary Pharmaceutical Division, United States. Mr. Stewart joined Abbott in 1992 and was first appointed as an AbbVie corporate officer in December 2018.
Roles
AbbVie Inc.
Executive Vice President, Chief Commercial Officer · Current role
Dec 2018–present
AbbVie
Senior Vice President, U.S. Commercial Operations
2018 - 2020
AbbVie
President, U.S. Commercial Operations
2013 - 2018
Abbott
Vice President, Proprietary Pharmaceutical Division, United States · Joined Abbott in 1992
—
Fixed Compensation
FY 2025Base Salary
$1,315,726
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$3,742,237
All Other Compensation
$737,376
Performance Compensation
Data from FY 2025Cash incentive
Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$2,950,000
Target Opportunity
—
ProgramAbbVie annual cash incentive plan
Stock awards
Stock Awards (grant-date fair value)
$5,390,310
VehiclesPerformance shares (EPS + relative TSR, 0-250% of target) and performance-vested RSUs (relative ROIC, 0-200% of target)
2025 resultAdjusted diluted EPS performance banked the 2025 performance-share award at 200% of target (TSR-modified vesting through Dec 31, 2027); relative ROIC vested one-third of the PVRSU award at 200% of target
Option Awards (grant-date fair value)
$1,299,655
VestingOne-third after each of years one, two and three of service
Also at AbbVie Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.